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Recently identified laminin isoforms containing the
a4 chain have been shown to be expressed in the base-
ment membrane of restricted organs such as heart, skel-
etal muscle, and blood vessels, especially those in em-
bryos. We screened 38 human cell lines for the
expression of the laminin a4 chain by reverse tran-
scriptase-polymerase chain reaction and found that
T98G glioblastoma cells express only a4, but not other a
chains. Laminin-8, an isoform containing the a4 and b1
chains, was purified from conditioned medium of T98G
cells by gel filtration and immunoaffinity chromatogra-
phy using a monoclonal antibody against laminin b1
chain. The purified laminin isoform was composed of
disulfide-linked 230-, 220-, and 200-kDa subunits, which
immunoblot analysis identified as the b1, g1, and a4
chains. Purified laminin-8 had cell adhesive activity
comparable to laminin-1 but significantly weaker than
laminin-5 and laminin-10/11. T98G cells adhering to
laminin-8 became more elongated than those adhering
to other laminin isoforms and extended multiple pseu-
dopods. Cell adhesion to laminin-8 was abolished by an
antibody against the integrin b1 subunit or a combina-
tion of antibodies against the integrin a3 and a6 sub-
units, but not by either anti-a3 or anti-a6 antibody alone,
suggesting that both a3b1 and a6b1 integrins serve as
adhesion receptors for laminin-8. Consistent with these
observations, K562 erythroleukemic cells transfected
with either integrin a3 or a6 cDNA were capable of ad-
hering to laminin-8 when b1 integrins were stimulated
by the b1-activating antibody 8A2. Despite its moderate
cell adhesive activity, laminin-8 was significantly potent
in promoting cell migration when compared with other
laminin isoforms and fibronectin. Cell migration on
laminin-8 was completely inhibited by a combination of
antibodies against a3 and a6 integrins, and substantially
inhibited by anti-a3 antibody alone, suggesting that
laminin-8-mediated cell migration is predominantly me-
diated by a3b1 integrin. Given its potency to stimulate
cell migration and preferential localization to the base-
ment membrane of capillaries and embryonic tissues,
laminin-8 may play a role in processes requiring en-
hanced cell migration during development, wound heal-
ing, and angiogenesis.
Laminins are the major class of basement membrane pro-
teins, composed of three disulfide-linked subunits, a, b, and g.
To date, five a, three b, and three g chains have been identified,
combinations of which have been shown to give rise to at least
12 different laminin isoforms (1–4). These laminin isoforms are
expressed in a tissue-specific and developmentally regulated
manner, suggesting that they are functionally distinct (5, 6).
The differences in biological activity among these isoforms,
however, have yet to be defined.
Laminins have many biological functions, including promo-
tion of cell adhesion and migration, control of cell proliferation
and gene expression, maintenance of differentiation pheno-
types, and stimulation of neurite outgrowth. Laminins mediate
these functions through binding to cell surface receptors, par-
ticularly the integrin family of cell adhesion molecules. So far,
nine integrin types, including a1b1, a2b1, a3b1, a6b1, a6b4, and
a7b1, have been shown to bind to laminins with distinct spec-
ificities (6, 7). For example, cell adhesion to laminin-1, the
“classical laminin” purified from mouse Engelbreth-Holm-
Swarm tumor, is mainly mediated by a6b1 integrin, while ad-
hesion to laminin-5 occurs through a3b1 and a6b4 integrins
(8–12). Laminin-2/4 is recognized by a3b1, a6b1, and a7b1 in-
tegrins, depending on the cell type (13, 14). We purified lami-
nin-10/11 from conditioned medium of lung carcinoma cells and
showed that it interacts with a3b1, a6b1, and a6b4 integrins (15,
16). Recently, the a4 chain-containing laminin isoform, lami-
nin-8, was reported to bind to a6b1 integrin (17, 18).
The a4 chain is a truncated version of the laminin a chains
like a3A (19, 20). The a4 chain is predominantly expressed in
capillaries in brain, muscle, and bone marrow (19, 21–24). In
the kidney, the a4 chain is present in nascent epithelial base-
ment membrane of the renal vesicle and immature glomerular
basement membrane, but is absent in the adult kidney (23, 25).
The a4 chain is also localized to muscle basement membrane
during muscle formation, but is absent in adult muscles, except
at neuromuscular junctions (26, 27). Similarly, laminin-8 is the
major laminin isoform in developing bone marrow (24). Despite
its restricted expression and localization in vivo, the biological
activity of the a4 chain-containing laminins has not been ex-
plored thoroughly due to the unavailability of sufficient puri-
fied laminin-8 for biochemical and functional analysis. In this
study, we purified laminin-8 from conditioned medium of hu-
man glioma cells and characterized its biological activities,
including cell adhesive and cell migration promoting properties
and integrin binding specificity in comparison with other lami-
nin isoforms and fibronectin.
EXPERIMENTAL PROCEDURES
Cell Culture—Human glioblastoma cell line T98G, human lung ad-
enocarcinoma cell line A549, human gastric cancer cell line AZ-521,
human hepatoma cell line HLF, and human gastric carcinoma cell line
MKN-45 were obtained from the Japanese Cancer Research Resources
Bank (Tokyo, Japan). Human lung squamous carcinoma cell line RERF-
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LC-AI was purchased from RIKEN Gene Bank (Tsukuba, Japan). These
cells were maintained in DMEM1 containing 10% FBS. K562 human
erythroleukemic cells transfected with cDNAs encoding human integrin
a3A or a6A subunits were kindly provided by Dr. Arnoud Sonnenberg
(The Netherlands Cancer Institute) and maintained in RPMI 1640
containing 10% FBS and 1 mg/ml Geneticin (13).
Antibodies—The mAb 8B12 against the human laminin a4 chain was
produced by fusion of Sp2/O mouse myeloma cells with spleen cells from
mice immunized with a glutathione S-transferase fusion protein con-
taining the G1 domain of the laminin a4 chain (Ser835-Cys1028 (20)). The
mAb 8B12 was capable of binding to denatured laminin a4 chain on
immunoblots, but not to intact a4 chain-containing laminin assembled
with b1 and g1 chains in an enzyme-linked immunosorbent assay, and
was therefore unsuitable for immunoaffinity purification of intact lami-
nins. The mAb 4F5 specific for the human laminin b1 chain was pro-
duced similarly to 8B12, except that spleen cells were obtained from
mice immunized with human placental laminin (Chemicon, Temecula,
CA). The specificity of 4F5 was determined by isolation and protein
sequencing of peptides from a thermolysin digest of human placenta
that selectively bound to 4F5-conjugated Sepharose 4B. The N-terminal
amino acid sequence of the 4F5-binding 60-kDa fragment was ARQX-
DRXLPGHWGFP, identical to the sequence of the human laminin b1
chain (Ala848-Pro862 (28)). The mAb 5D6 against the human laminin a5
chain, was produced by immunizing mice with commercially available
human laminin-10/11 (Chemicon) purified from a pepsin digest of hu-
man placenta by immunoaffinity chromatography using the anti-a5
chain mAb 4C7 (29, 30). The mAb 5D6 was selected by positive reac-
tivity with purified human laminin-10/11 (15) and negative reactivity
with commercially available human laminin-2/4 (Chemicon). The mAb
2B10 against the laminin a3 chain was produced by immunizing mice
with human laminin-5 purified from conditioned medium of MKN-45
cells (31). 2B10 was selected by reactivity with purified laminin-5 in an
enzyme-linked immunosorbent assay, followed by specific binding to
the laminin a3 chain as shown on immunoblots. mAbs against the
human laminin a1 (5A3) and a5 (15H5) chains were produced in our
laboratory as described previously (15). A mAb against the laminin b1
chain (DG10) was kindly provided from Dr. Ismo Virtanen (University
of Helsinki, Finland). A hybridoma secreting mAb against the laminin
b2 chain (C4), developed by Dr. Joshua Sanes (Washington University
School of Medicine), was obtained from the Developmental Studies
Hybridoma Bank (University of Iowa). MAbs against the human lami-
nin a2 chain (5H2) and human integrin a2 (P1E6) were purchased from
Chemicon. MAbs against the human laminin g1 chain (2E8 and number
22) were obtained from Chemicon and Transduction Laboratories (Lex-
ington, KY), respectively. A mAb against the human integrin a6 (GoH3)
was purchased from Immunotech (Westbrook, ME). MAbs against the
human integrin a3 (3G8), a5 (8F1), and b1 (4G2) chains were produced
in our laboratory as described previously (16, 32). A mAb against
integrin b1 (8A2) which activates b1 chain-containing integrins, was a
gift from Dr. Nicholas Kovach (University of Washington, Seattle, WA).
Adhesive Proteins—Mouse laminin-1 was purified from mouse En-
gelbreth-Holm-Swarm tumor tissues by the method of Paulsson et al.
(33). Human laminin-5 was purified from conditioned medium of
MKN45 cells by immunoaffinity chromatography using polyclonal an-
tibodies against the human laminin g2 chain (31). Human laminin-
10/11 was purified from conditioned medium of A549 cells according to
Kikkawa et al. (15), except that mAb 5D6, instead of 4C7, was used to
conjugate Sepharose 4B in the immunoaffinity matrix. Human lami-
nin-1 was isolated from conditioned medium of RERF-LC-AI cells on a
4F5 immunoaffinity column and used only for immunoblot analysis.
Human laminin-2/4 (also referred to as merosin) was purchased from
Chemicon. Human plasma fibronectin was purified from outdated
plasma by gelatin affinity chromatography (34).
Screening of Cultured Cells for Expression of Laminin a Chains by
RT-PCR—Total RNA was extracted from 38 human cell lines (13 lung
carcinomas, 5 gastric carcinomas, 3 gliomas, 2 kidney carcinomas, 2
cervix carcinomas, 2 tropoblastomas, 2 endothelial cell lines, and one
each of oral carcinoma, salivary grand carcinoma, rhabdomyosarcoma,
leukemia, hepatoma, pancreatic carcinoma, epidermoid carcinoma, fi-
brosarcoma, and lung fibroblast) by the acid guanidinium isothiocya-
nate method (35) and used as templates for cDNA synthesis. cDNAs
encoding each of five distinct laminin a chains were amplified by PCR
using the following pairs of primers; 59-AAGTGTGAAGAATGTGAGG-
ATGGG-39 (forward primer for a1; nucleotides 3020–3043 (36)) and
59-CACTGAGGACCAAAGACATTTTCCT-39 (reverse primer for a1;
nucleotides 3312–3336); 59-AAATGTACAGAGTGCAGTCGAGGTCA-39
(forward primer for a2; nucleotides 3314–3339 (37)) and 59-CAGTGG-
ATGCCTTCCACATTCACCTT-39 (reverse primer for a2; nucleotides
3458–3483); 59-CACTGTGAACGCTGCCAGGAGGGCTA-39 (forward
primer for a3; nucleotides 280–305 (38)) and 59-CAGCTACCTCCGAA-
TTTCTGGGGATT-39 (reverse primer for a3; nucleotides 466–491); 59-
CACTGTGAAAAGTGTCTGGATGGT-39 (forward primer for a4; nuc-
leotides 608–631 (20)) and 59-CAGGTGCTTCCAATGAGGAAGGGG-39
(reverse primer for a4; nucleotides 811–834); 59-GACTGCCTGCTGTG-
CCAGC-39 (forward primer for a5 (15)) and 59-GGGGTAGCCATGAA-
AGCCCG-39 (reverse primer for a5); 59-AACTGTGAGCAGTGCAAGC-
CGTTT-39 (forward primer for b1; nucleotides 1054–1077 (39)) and
59-CAACCAAATGGATCTTCACTGCTT-39 (reverse primer for b1; nuc-
leotides 1278 –1301); 59-CACTGTGAGCTCTGTCGGCCCTTC-39
(forward primer for b2; nucleotides 1153–1176 (40)) and 59-CAAGGA-
GTGCTCCCAGGCACTGTG-39 (reverse primer for b2; nucleotides
1427–1451); and 59-CACTGTGAGAGGTGCCGAGAGAAC-39 (forward
primer for g1; nucleotides 1033–1056 (41)) and 59-CATCCTGCTTCAG-
TGAGAGAATGG-39 (reverse primer for g1; nucleotides 1203–1226).
PCR products were analyzed by electrophoresis using 2% agarose gels.
Purification of Laminin-8—T98G cells were grown in 1,700-cm2
roller bottles with DMEM containing 10% FBS. After the cells reached
confluence, the medium was replaced with DMEM containing 5% FBS
and harvested every 6 days. The conditioned medium (about 4 liters)
was clarified by centrifugation and then precipitated with 45% satu-
rated ammonium sulfate. The precipitates were dissolved in 10 ml of 25
mM Tris-HCl (pH 7.4) containing 1 mM EDTA, clarified by centrifuga-
tion, and subjected to gel filtration on a Sepharose CL-4B column (2.5 3
120 cm) equilibrated in PBS containing 0.5 mM phenylmethylsulfonyl
fluoride, 0.5 mM N-ethylmaleimide, and 1 mM EDTA. The Sepharose
CL-4B column was calibrated prior to use with mouse laminin-1 (;800
kDa), human plasma fibronectin (;450 kDa), and mouse IgG (150 kDa).
Fractions containing laminin-8 were detected by immunoblotting with
anti-a4 mAb 8B12. These fractions were pooled and then applied to a
4F5-conjugated Sepharose 4B column equilibrated in PBS containing
0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM N-ethylmaleimide, 5 mM
EDTA, 0.5 mg/ml aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin.
The bound proteins were eluted with 0.1 M glycine-HCl (pH 2.4), im-
mediately neutralized with 1.5 M Tris-HCl (pH 9.0), and dialyzed
against PBS containing 1 mM EDTA.
Cell Adhesion Assay—Cell adhesion assays were performed as de-
scribed previously (15) with minor modifications. Ninety-six-well mi-
crotiter plates (Nunc, Wiesbaden, Germany) were coated with 50 ml of
increasing concentrations of cell adhesive proteins overnight at 4 °C,
and then blocked with PBS containing 2% BSA at 37 °C for 1 h. 100-ml
aliquots of cell suspension (3 3 105 cells/ml in serum-free DMEM
containing 10 mM HEPES (pH 7.4) and 0.5% BSA) were added to each
well of the coated plates and incubated at 37 °C for 30 min in a CO2
incubator. After the plates were washed to remove unattached cells,
attached cells were fixed with 3.7% formaldehyde, stained with Diff-
Quik (International Reagents Corp., Kobe, Japan), and counted in three
independent fields/well. For cell adhesion assays using K562 cells, cell
suspensions (4 3 105 cells/ml in serum-free RPMI 1640 containing 10
mM HEPES (pH 7.4) and 0.5% BSA) were preincubated with or without
8A2, an integrin b1-activating mAb, for 10 min at room temperature.
50-ml aliquots of preincubated cell suspension were added to 96-well
microtiter plates coated with increasing concentrations of various lami-
nin isoforms and incubated at 37 °C for 30 min in a CO2 incubator.
Attached cells were counted as described above.
Cell adhesion inhibition assays were performed based on the cell
adhesion assays. Cell suspensions (4 3 105 cells/ml in serum-free
DMEM containing 10 mM HEPES (pH 7.4) and 0.5% BSA) were incu-
bated with 20 mg/ml mAbs against different integrin isoforms for 20 min
at room temperature. 50-ml aliquots of preincubated cells were added to
wells that had been coated with different cell adhesive proteins and
incubated for 30 min at 37 °C in a CO2 incubator. Attached cells were
then counted as described above.
Cell Migration Assay—Cell migration on substrates coated with
laminins or fibronectin was examined by time lapse video microscopy
using the image processing software Image-Pro Plus (Media Cybernet-
ics, Silver Spring, MD). Glass-bottom culture dishes fitted with f 8-mm
coverslips were coated with 250 ml of cell adhesive proteins overnight at
4 °C, and blocked with PBS containing 2% BSA at 37 °C for 1 h. 4-ml of
cell suspension (1 3 104 cells/ml in DMEM containing 1% FBS) was
1 The abbreviations used are: DMEM, Dulbecco’s modified Eagle’s
medium; FBS, fetal bovine serum; mAb, monoclonal antibody; RT-PCR,
reverse transcription-polymerase chain reaction; PBS, phosphate-buff-
ered saline; BSA, bovine serum albumin; PVDF, polyvinylidene difluo-
ride; PAGE, polyacrylamide gel electrophoresis.






















added to each coated dish and incubated at 37 °C for 30 min to allow the
cells to attach. The dishes were then placed in a built-in CO2 incubator
on the stage of the Zeiss Axiovert 25 microscope, and subjected to time
lapse video microscopy at 10-min intervals for 8 h. Cell migration was
quantified by tracing the position of the nucleus of migration cells using
Image-Pro Plus.
For cell migration inhibition assays, cell suspensions (2 3 104
cells/ml in DMEM containing 1% FBS) were incubated with 20 mg/ml
mAbs against different integrin isoforms for 20 min at room tempera-
ture. 2-ml of preincubated cell suspension was added to the precoated
glass-bottom culture dishes and incubated at 37 °C for 30 min to allow
cells to attach. Cell migration images were taken as described for cell
migration assays for 8 h.
SDS-PAGE and Immunoblotting—SDS-PAGE was carried out ac-
cording to Laemmli (42) using 4 or 5.5% acrylamide gels. Separated
proteins were visualized by silver staining or transferred onto PVDF
membranes. The membranes were probed with mAbs against individ-
ual laminin chains, followed by visualization using the ECL detection
kit (Amersham Pharmacia Biotech).
RESULTS
Screening of Human Cell Lines for Selective Expression of the
Laminin a4 Chain—To purify laminin isoforms containing the
a4 chain from conditioned medium of cultured cells, we
screened 38 human cell lines for selective expression of the
laminin a4 chain by RT-PCR. We found that one of the glioma
cell lines, T98G, expresses only one of the five known laminin
a chains, the a4 chain (Fig. 1A). Failure to detect RNA tran-
scripts for other a chains was not due to inappropriate PCR
conditions, since these transcripts were clearly detected in
other cell lines, including the a1 chain in RERF-LC-AI, a2 and
a3 chains in HLF, and a5 chain in AZ521. T98G cells also
expressed b1 and g1 chains, but only a low level of the b2 chain
(Fig. 1B), indicating that laminin-8 (a4b1g1) is the major lami-
nin isoform expressed in T98G cells.
The expression of laminin-8 in T98G cells was confirmed at
the protein level by immunoblot analysis of conditioned me-
dium of T98G cells using mAb 8B12 produced by immunizing
mice with a recombinant G1 domain of the human a4 chain.
The mAb 8B12 specifically detected a ;650-kDa band under
nonreducing conditions, while reducing conditions resulted in a
major 200-kDa band and a faint 180-kDa band (Fig. 1C). The
200-kDa band is consistent with the molecular mass of the
laminin a4 chain as predicted by its amino acid sequence (19,
20), confirming that T98G cells synthesize and secrete the a4
chain as a disulfide-linked heterotrimer with b1 and g1 chains.
Purification of Laminin-8—Laminin-8 secreted by T98G
cells was purified from conditioned medium by ammonium
sulfate precipitation, gel filtration, and immunoaffinity chro-
matography using mAb 4F5 specific for the laminin b1 chain.
Conditioned medium of T98G cells was precipitated with 45%
saturated ammonium sulfate, and the precipitates were sub-
jected to gel filtration on a Sepharose CL-4B column (Fig. 2).
Fractions containing trimeric laminin-8 were detected by im-
munoblotting with 8B12, an anti-a4 chain mAb, pooled, and
subjected to immunoaffinity chromatography using 4F5. The
eluate from the 4F5-Sepharose column was found by silver
staining to contain a single 650-kDa species under nonreducing
conditions (Fig. 3A). The ;650-kDa band was stained with
mAbs specific for the a4, b1, and g1 chains, confirming that the
purified protein was laminin-8. Under reducing conditions,
three bands of 230, 220, and 200 kDa were resolved, each
identified as the b1, g1, and a4 chains, respectively, by immu-
noblot analysis (Fig. 3B). A faint 180-kDa band was also de-
tectable by immunoblotting with anti-a4 mAb. Since the 180-
kDa band was also detectable in fresh conditioned medium
(Fig. 1C), it could be a proteolytically processed a4 chain or an
FIG. 1. Expression of laminin-8 in human tumor cell lines. A,
transcripts for a1, a2, a3, a4, and a5 chains of human laminin were
amplified by RT-PCR from T98G human glioblastoma cells, RERF-
LC-AI human lung carcinoma cells, HLF human hepatoma cells, and
AZ521 human gastric carcinoma cells, using the primers described
under “Experimental Procedures.” The predicted size of the amplified
cDNAs were 317 (a1), 168 (a2), 212 (a3), 227 (a4), and 197 (a5) base
pairs. B, transcripts for b1, b2, and g1 chains of human laminin were
amplified by RT-PCR from T98G cells, using the primers described
under “Experimental Procedures.” The predicted size of the amplified
cDNAs were 248 (b1), 299 (b2), and 194 (g1) base pairs. C, the a4
chain-containing laminins in conditioned medium of T98G cells were
detected by immunoblot analysis. Conditioned medium of T98G cells
was separated by SDS-PAGE on 4% gels under nonreducing conditions
or on 5.5% gels under reducing conditions. The separated proteins were
transferred onto PVDF membranes followed by immunostaining with
8B12, a mAb against the laminin a4 chain. Shown in the margin are the
positions of molecular weight markers.
FIG. 2. Size fractionation of conditioned medium of T98G cells
by gel filtration. Conditioned medium of T98G cells (about 4 liters)
was precipitated with 45% saturated ammonium sulfate, and the pre-
cipitates were subjected to gel filtration on a Sepharose CL-4B column
(2.5 3 120 cm). The column was calibrated with mouse laminin-1 (;800
kDa), human plasma fibronectin (450 kDa), and mouse IgG (150 kDa)
prior to use. Arrows indicate the positions where laminin-1, fibronectin,
and IgG eluted. Fractions containing laminin-8 were detected by im-
munoblotting with anti-a4 chain mAb 8B12 under nonreducing condi-
tions. Fractions 37–53 were pooled and subsequently subjected to im-
munoaffinity chromatography.






















alternatively spliced variant. Since no bands near 150 kDa
were detected by silver staining under reducing or nonreducing
conditions, the purified laminin-8 seemed to be devoid of
nidogen-1.
To confirm the absence of other laminin isoforms in the
purified laminin-8, we examined the reactivity of the purified
laminin-8 with mAbs specific for each laminin chain by immu-
noblotting. Purified laminin-8 was strongly stained by a mAb
against the a4 chain, but not by mAbs against the a1, a2, a3,
a5, or b2 chains (Fig. 4A), demonstrating the absence of other
a chain-containing laminin isoforms and the b2 chain-contain-
ing laminin-9 (a4b2g1). When a mAb against the g1 chain was
used as a probe against purified laminin-8, only the 650-kDa
band was labeled, while 700–800-kDa bands were detected in
purified laminin-1, laminin-2/4, and laminin-10/11 samples
(Fig. 4B). The absence of a 700–800-kDa band in laminin-8
purified from conditioned medium of T98G cells further con-
firmed the absence of any contaminating laminin isoforms.
Cell Adhesive Activity of Laminin-8—Cell adhesive activity
of laminin-8 was compared with that of other laminin isoforms
(i.e. laminin-1, laminin-2/4, laminin-5, and laminin-10/11) and
fibronectin using T98G cells as substrate. Laminin-8 was a less
potent mediator of cell adhesion than laminin-5 and laminin-
10/11, and was comparable to laminin-1 (Fig. 5). Half-maximal
levels of T98G cell adhesion were achieved at a substrate
coating concentration of 2.5 nM for laminin-5 and laminin-10/
11, and 5 nM for laminin-8 and laminin-1.
Cell adhesion to laminins is mainly mediated by integrins.
We examined the effects of function blocking mAbs against
various integrin subunits on adhesion of T98G cells to lami-
nin-8 to determine the major integrin type(s) that serves as its
adhesion receptor(s) (Fig. 6). As previously demonstrated (9,
10, 15, 31), cell adhesion to laminin-1, laminin-5, and fibronec-
tin is specifically inhibited by mAbs against integrins a6, a3,
and a5, respectively. The mAb against integrin b1 also inhibit
cell adhesion to these proteins. In contrast, the adhesion of
T98G cells to laminin-8 is not inhibited by any single mAb,
except for anti-b1 mAb. When combined, however, mAbs
against a3 and a6 were found to strongly inhibit the adhesion
of T98G cells to laminin-8, indicating that T98G cells adhere to
laminin-8 through both a3b1 and a6b1 integrins.
To confirm the dual integrin specificity of laminin-8, we
examined the laminin-8 adhesion of K562 human erythroleu-
kemic cells transfected with integrin a3 or a6 in the absence or
presence of 8A2, an anti-b1 activating mAb (Fig. 7). Untrans-
fected K562 cells, shown to express only the a5 subtype of b1
integrin (13, 43), could not adhere to all laminin isoforms
examined, regardless of the absence or presence of the b1-
activating mAb. K562 cells expressing the integrin a6 subunit
together with endogenous b1 were competent in adhering to
laminin-8 and, to a lesser extent, to laminin-5, but not to
laminin-1, in the absence of mAb 8A2. Upon b1 integrin stim-
ulation by 8A2, a6-transfected cells became highly adherent to
all these laminin isoforms with similar potencies. In contrast,
a3-transfected cells expressing a3b1 integrin were only capa-
ble of adhering to laminin-5, and did not respond to laminin-1
or laminin-8 in the absence of mAb 8A2 stimulation. Upon 8A2
stimulation, however, a3-transfected cells became adherent to
laminin-8. Adhesion of the stimulated a3-transfected cells to
laminin-8 was not due to increased nonspecific adhesiveness of
these cells, as they remained nonadherent to laminin-1. These
results confirmed that both a3b1 and a6b1 integrins could
serve as the adhesion receptors for laminin-8, but that the
latter may act as the preferred receptor for laminin-8, since
a6-transfected, but not a3-transfected K562 cells adhere to
laminin-8 without stimulation by 8A2.
Cell Migration Promoting Activity of Laminin-8—Laminins
have been shown to stimulate cell migration during develop-
ment and in many pathological processes (44–46). We exam-
ined the ability of laminin-8 to promote cell migration by using
time lapse video microscopy to track T98G cells migrating on
dishes coated with different concentrations of laminin-8 or
other adhesive proteins. Among the six different adhesive li-
gands examined, laminin-8 was most potent in promoting cell
migration, attaining maximal activity at coating concentra-
tions of .10 nM without a significant decline up to 80 nM (Fig.
8). Laminin-10/11 was also very potent in promoting cell mi-
gration, attaining maximal activity at coating concentrations of
5–10 nM. Laminin-2/4 and laminin-5 were of roughly equal
potency, lower than laminin-8 and laminin-10/11, while lami-
nin-1 was weaker still. Fibronectin was barely active, if at all,
in promoting migration of T98G cells.
Cell migration promoting activity of all six adhesive ligands
except laminin-8 declined at higher coating concentrations,
consistent with previous observations (47–49) that cell migra-
tion speed was dependent on the adhesive strength of cells to
substratum, giving a biphasic dose-response curve when sub-
strates are coated with increasing concentrations of adhesive
ligands. Laminin-8 also strongly promoted migration of other
cell types, including A549 human lung adenocarcinoma cells, to
a similar degree as was demonstrated with T98G cells (data not
shown).
T98G cells migrating on laminin-8 assumed an elongated
morphology with frequent pseudopod extension in the direction
of cell migration (Fig. 9). Small lamellipodia-like structures
were observed at the tip of the pseudopods. The cells plated on
laminin-8-coated substrates were capable of easily detaching
from the substratum at the rear, allowing them to crawl
smoothly. A similar elongated morphology with pseudopods
extended in the direction of cell migration was observed with
cells plated on substrates coated with laminin-2/4 and laminin-
10/11, but not with laminin-1, laminin-5, or fibronectin. Cells
on laminin-1, laminin-5, or fibronectin-coated substrates as-
sumed rather round morphologies with wide lamellipodia ex-
tending in multiple directions from time to time, thereby pre-
FIG. 3. SDS-PAGE and immunoblot analysis of purified lami-
nin-8. Laminin-8 purified from conditioned medium of T98G cells was
analyzed by SDS-PAGE on 4% gels under nonreducing conditions (A) or
on 5.5% gels under reducing conditions (B). Separated proteins were
visualized by silver staining or transferred onto PVDF membranes
followed by staining with mAbs against laminin a4 (8B12), b1 (DG10),
or g1 (2E8 under nonreducing conditions and mAb number 22 under
reducing conditions) chains. The positions of molecular size markers
are shown in the left margin.






















venting them from becoming polarized. There was a close
correlation between the ability of the substrates to polarize
cells and their potency in promoting cell migration.
To explore whether both a3b1 and a6b1 integrins are in-
volved in cell migration on laminin-8, we examined the effects
of function-blocking mAbs against different integrin subunits
on T98G cell migration on laminin-8-coated substrates. The
mAb against a3 integrin strongly inhibited laminin-8-mediated
cell migration, but an anti-a6 integrin mAb was only margin-
ally inhibitory (Fig. 10). The combination of a3 and a6 integrin
mAbs completely inhibited cell migration. These results indi-
cate that cell migration on laminin-8 is predominantly driven
by the interaction of a3b1 integrin with laminin-8.
DISCUSSION
In this study, we purified laminin-8 from conditioned me-
dium of T98G cells by affinity chromatography using a mAb
specific for the laminin b1 chain. T98G cells were used as a
source of laminin-8 because these cells express only the a4
subtype of laminin a chain. Selective expression of the a4 chain
was confirmed at both the RNA and protein level by RT-PCR
and immunoblot analysis. Although mAb 8B12 recognizes only
denatured, and not intact, a4 chains, and cannot be used as an
affinity ligand for purification, selective expression of the a4
chain in T98G cells allowed us to purify laminin-8 by affinity
chromatography using mAb against the laminin b1 chain. The
identity of the purified laminin-8 was confirmed by its positive
reactivity with mAbs against the a4, b1, and g1 chains. The
absence of other contaminating laminin isoforms was estab-
lished by negative reactivity to a panel of mAbs recognizing
each one of the other four known a chains. Furthermore, lami-
nin-9 (a4b2g1) was shown to be absent from the purified lami-
nin-8, as evidenced by a lack of reactivity with a mAb against
the b2 chain. Immunoblotting of purified laminin-8 with an
anti-a4 chain mAb detected a major 200-kDa band, together
with a minor 180-kDa band. The 180-kDa band was also de-
tectable in conditioned medium of T98G cells, suggesting that
the 180-kDa a4 chain could be a proteolytically processed form
or an alternatively spliced form. A similar 180-kDa a4 chain
FIG. 4. Immunoblot analysis of puri-
fied laminin-8 with mAbs against dis-
tinct laminin chains. A, purified lami-
nin-8 was subjected to immunoblotting with
mAbs against distinct laminin a chains or
with a mAb against the b2 chain to confirm
the absence of other laminin isoforms. Equal
amounts (0.4 mg/lane) of purified human
laminin-1 (LN-1), laminin-2/4 (LN-2/4),
laminin-5 (LN-5), laminin-8 (LN-8), and
laminin-10/11 (LN-10/11) were separated
by SDS-PAGE on 4% gels under nonreduc-
ing conditions and transferred onto PVDF
membranes followed by staining with mAbs
against the laminin a1 (5A3), a2 (5H2), a3
(2B10), a4 (8B12), a5 (15H5), or b2 (C4)
chains. The mAb against the laminin a2
chain reacts with the 80-kDa fragment de-
rived from the C-terminal region of the a2
chain. B, equal amounts (0.4 mg/lane) of pu-
rified human laminin-1 (LN-1), laminin-2/4
(LN-2/4), laminin-8 (LN-8), and laminin-
10/11 (LN-10/11) were similarly subjected
to immunoblotting with anti-g1 mAb 2E8 as
described above. The positions of molecular
size markers are shown in the left margin.
FIG. 5. Cell adhesive activity of laminin-8. T98G cells were incu-
bated at 37 °C for 30 min on 96-well microtiter plates coated with
increasing concentrations of laminin-1 (LN-1), laminin-5 (LN-5), lami-
nin-8 (LN-8), laminin-10/11 (LN-10/11), or fibronectin (FN). The plates
were washed with serum-free DMEM three times to remove unattached
cells, after which attached cells were fixed and counted under a micro-
scope. Bars represent the standard deviation of triplicate assays.
FIG. 6. Effects of anti-integrin mAbs on adhesion of T98G cells
to laminin-8 and other adhesive proteins. Ninety-six-well microti-
ter plates were coated with 8 nM laminin-1 (LN-1), 2.5 nM laminin-5
(LN-5), 8 nM laminin-8 (LN-8), or 8 nM fibronectin (FN). The coating
concentrations of adhesive ligands were chosen to obtain near-maximal
levels of cell adhesion in the absence of blocking mAbs. T98G cells were
preincubated with the following function-blocking mAbs against inte-
grin subunits at a concentration of 20 mg/ml IgG for 20 min at room
temperature and then added to the precoated wells: a2, anti-integrin a2
subunit mAb (P1E6); a3, anti-integrin a3 subunit mAb (3G8); a5, anti-
integrin a5 subunit mAb (8F1); a6, anti-integrin a6 subunit mAb
(GoH3); and b1, anti-integrin b1 subunit mAb (4G2). After 30 min
incubation at 37 °C, cells attached to the substrates were counted under
a microscope. The number of adhering cells is expressed as a percentage
of the number of cells adhering in the presence of control mouse IgG.
Each column and bar represents the mean of triplicate assays and the
standard deviation, respectively.






















was also detected in laminin-8 purified from platelets (17).
Both a3b1 and a6b1 integrins function as the major cell
surface receptors for laminin-8, based on the following obser-
vations: 1) adhesion of T98G cells to laminin-8 was not inhib-
ited by any single mAb against the integrin a2, a3, a5, or a6
chain, but inhibited by an anti-b1 integrin mAb or a combina-
tion of anti-a3 and anti-a6 mAbs. 2) Wild-type K562 cells could
not adhere to laminin-8 even after stimulation of b1 integrins
by 8A2, whereas K562 cells transfected with a3 or a6 integrin
subunits could adhere to laminin-8. a6-Transfected cells ad-
hered to laminin-8 without b1 integrin stimulation, but a3-
transfected cells needed b1 integrin activation to adhere to
laminin-8, indicating that although both a3b1 and a6b1 could
serve as adhesion receptors for laminin-8, a6b1 might be the
preferred laminin-8 receptor. The role of a6b1 integrin as the
laminin-8 receptor was recently reported using platelet lami-
nin-8 (17) and recombinant laminin-8 (18). Geberhiwot et al.
(17) showed that platelet adhesion to laminin-8 is inhibited by
anti-a6 mAb alone, in contradiction to our present observa-
tions. This could be due to a very low level, if at all, of expres-
sion of a3b1 integrin in platelets (50), while platelets have been
shown to express a6b1 integrin that is functionally active in
mediating platelet adhesion to laminin-1 (51).
Recently, Kortesmaa et al. (18) produced recombinant lami-
nin-8 in a mammalian expression system by triple transfection
of human laminin a4 and g1, and mouse b1 chains, with an
acidic FLAG-tag attached to the C terminus of the a4 chain.
They showed that K562 cells expressing a6b1 integrin could
adhere to recombinant laminin-8 without integrin stimulation.
They also reported that K562 cells expressing a3b1 integrin
adhere poorly to recombinant laminin-8, although they did not
show the data, nor did they indicate whether the assays were
done with or without integrin stimulation. Their results are
consistent with our observations, except that they did not in-
dicate whether a3-transfected cells could adhere to recombi-
nant laminin-8 with integrin stimulation. They also reported,
however, that adhesion of HT1080 cells to recombinant lami-
nin-8 was strongly inhibited by the anti-integrin a6 mAb alone,
while our data show that both anti-a3 and anti-a6 mAbs are
necessary to inhibit adhesion of T98G cells to laminin-8. This
apparent discrepancy is not due to contamination of our lami-
nin-8 preparation, which has been determined by immunoblot
analysis to be free of laminin isoforms containing a1, a2, a3, or
a5 chains, as well as the b2 chain-containing laminin-9. Lami-
nins have been shown to undergo post-translational modifica-
tions such as proteolytic processing and N- and O-linked gly-
FIG. 7. Adhesion of K562 transfectants expressing a3b1 and a6b1 integrins to different laminin isoforms. Control K562 cells and those
expressing integrin a3b1 (K562/a3b1) or a6b1 (K562/a6b1) were incubated for 30 min at 37 °C with or without the stimulatory mAb 8A2 (1:10,000
dilution of ascites) in 96-well microtiter plates precoated with increasing concentrations of laminin-1 (LN-1), laminin-5 (LN-5), and laminin-8
(LN-8). Cells adhering to the substrates were fixed, stained, and counted as described under “Experimental Procedures.” Each point and bar
represents the mean of triplicate assays and the standard deviation, respectively.
FIG. 8. Cell migration promoting activity of laminin-8. Glass-
bottom culture dishes were precoated with increasing concentrations of
laminin-1 (LN-1), laminin-2/4 (LN-2/4), laminin-5 (LN-5), laminin-8
(LN-8), laminin-10/11 (LN-10/11), or fibronectin (FN). T98G cells were
added to the precoated dishes and the migrating cells were tracked by
time lapse video microscopy at 37 °C for 8 h. Cell migration paths were
traced and quantified using the Image-Pro Plus image-processing soft-
ware. Each point represents the mean of migration distances of 10
different migrating cells.






















cosylation (52, 53), which may explain the discrepancy in the
integrin-binding specificity between the recombinant lami-
nin-8 and the laminin-8 that we purified. The recombinant
laminin-8 was produced in human embryonic kidney cells,
while our laminin-8 was produced in human glioma cells. Cell
type-dependent glycosylation and/or proteolytic processing of
subunit chains may therefore modify the integrin-binding spec-
ificity of laminin-8. Differences in elution protocols for immu-
noaffinity purification of laminin-8 may also explain the appar-
ent discrepancy in integrin-binding specificity between the
recombinant laminin-8 and our laminin-8 preparation. Al-
though the recombinant laminin-8 was eluted from an anti-
FLAG immunoaffinity column under nondenaturing conditions
using the FLAG peptide, our laminin-8 was eluted from an
anti-b1 mAb column under denaturing conditions using 0.1 M
glycine-HCl (pH 2.4). It should be also noted that the recombi-
nant laminin-8 is a hybrid protein consisting of human a4 and
g1 chains assembled with a mouse b1 chain, with an acidic
FLAG-tag attached to the C terminus of the a4 chain. It is
possible that such non-physiological features associated with
the recombinant expression system also modify the integrin-
binding specificity of laminin-8.
Although both anti-a3 and anti-a6 integrin mAbs were
needed to inhibit adhesion of T98G cells to laminin-8, cell
migration on laminin-8-coated substrate was strongly inhibited
by anti-a3 mAb alone. It seems, therefore, that a3b1, but not
a6b1, integrin is the major adhesion receptor through which
laminin-8 mediates cell migration. In support of this notion,
a3b1 integrin has been shown to serve as the principal adhe-
sion receptor in migration of various cell types. For example,
migration of neurons along radial glial fibers during develop-
ment of the cerebral cortex is dependent on a3b1 integrin (54).
Migration of keratinocytes during wound healing is also medi-
ated primarily by a3b1 integrin with concomitant deposition of
laminin-5 (46). Integrin a3b1 has also been shown to serve as
the major integrin receptor operating in the migration and
invasion of various tumor cells (31, 55). The prevalence of a3b1
integrin in cell migration processes may explain the varied
responses to different laminin isoforms. The observation that
laminin-1 is a much weaker promoter of cell migration than
laminin-8, even though they have similar cell-adhesive activ-
ity, may be because laminin-1 does not act through a3b1 inte-
grin as an adhesion substrate. In contrast, laminin-2/4, lami-
nin-5, and laminin-10/11, all of which are ligands for a3b1
integrin (12, 15, 31), were more potent than laminin-1 in pro-
moting cell migration, further supporting the role of a3b1
integrin as a preferred receptor for this specific activity.
For a cell to migrate, the cell needs to extend membrane
ruffles in the direction of cell migration and become polarized.
T98G cells adhering to laminin-8 assumed a highly polarized
morphology with extension of multiple pseudopods in the di-
rection of cell migration. A similar polarized morphology was
also observed in cells adhering to laminin-10/11, and, to lesser
extent, in cells adhering to laminin-2/4. In contrast, laminin-1
and fibronectin, both of which were very weak promoters of cell
migration, did not induce morphological polarization, consist-
ent with the close correlation between the ability of cells to
become polarized and to migrate (48). Although the mecha-
nisms of cell polarization are not well understood, it seems
likely that the Rho family of small GTPases, particularly Rac
and Cdc42, play critical roles in this phenomenon through
promoting lamellipodia and filopodia formation (56, 57). It has
been established that activation of Rac and Cdc42 is involved in
FIG. 9. Morphology of T98G cells migrating on the substrates
coated with laminin-8 and other adhesive proteins. T98G cells
were plated onto glass-bottom culture dishes precoated with 10 nM
laminin-1 (LN-1), laminin-2/4 (LN-2/4), laminin-5 (LN-5), laminin-8
(LN-8), laminin-10/11 (LN-10/11), or fibronectin (FN). Cells were incu-
bated on the substrates for 30 min to allow them to attach, after which
migrating cells were recorded by time lapse video microscopy at 30-min
intervals for 2.5 h. Arrowheads indicate pseudopods extended in the
direction of cell migration. Bar, 100 mm.
FIG. 10. Effects of anti-integrin mAbs on migration of T98G
cells adhering to laminin-8. Glass-bottom culture dishes were pre-
coated with 20 nM laminin-8. T98G cells were preincubated with the
following function blocking mAbs against integrin subunits at a con-
centration of 20 mg/ml IgG for 20 min at room temperature and then
added to the precoated dishes: IgG, control mouse IgG; a3, anti-integrin
a3 subunit mAb (3G8); and a6, anti-integrin a6 subunit mAb (GoH3).
Cell migration images were acquired by time lapse video microscopy at
10-min intervals for 8 h. Cell migration was quantified as described
under “Experimental Procedures.” Each column represents the mean of
migration distances of 10 different migrating cells. Bars represent the
standard deviation.






















extension of lamellipodia and filopodia, respectively. Thus, the
prominent cell polarization with multiple pseudopod extension
observed to be induced by laminin-8 may be associated with
activation of Rac and/or Cdc42. Ligation of a3b1 integrin by
anti-a3 mAbs has been shown to induce curtain-like lamellipo-
dia in skin fibroblasts adhering to laminin-1, which usually is
associated with the adoption of a typical fibroblastic morphol-
ogy with dense focal contacts (58). This suggests that ligation of
a3b1 integrins transduces signals that activate Rac. Consist-
ent with this view, a3b1 integrin has been shown to negatively
regulate actin cytoskeletal reorganization. For example, abla-
tion of a3b1 by gene targeting in keratinocytes and kidney
epithelial cells resulted in enhanced stress fiber formation and
denser focal contacts (59, 60). Since Rac has been shown to
down-regulate Rho activity (61, 62), it seems likely that a3b1
integrin transduces signals that activate Rac, which in turn
down-regulates Rho and suppresses formation of stress fibers
and focal contacts. For a cell to migrate, it needs to detach from
the substratum at its rear edge. Formation of focal contacts
stabilized by stress fibers is disadvantageous for this cell de-
tachment. Enhanced cell migration on laminin-8 may be due to
the suppression of this stabilization mechanism. Indeed, cells
migrating on laminin-8-coated substrates were not only highly
polarized, but also frequently became rounded during migrat-
ion (data not shown), consistent with this proposed mechanism.
Cell migration speed has been shown to exhibit a biphasic
dependence on adhesive ligand concentration, regardless of
integrin expression level or integrin-ligand binding affinity
(49). Our data also show that cell migration on various types of
laminin isoforms, except laminin-8, follows a biphasic curve as
the substratum was coated with increasing concentrations of
the adhesive ligands. The reason why cell migration speed did
not decline when laminin-8 was used at high coating concen-
trations (i.e. up to 80 nM) is not clear, but it is conceivable that
formation of focal contacts and stress fibers, the major suppres-
sor of cell detachment at the rear, was not induced under these
conditions, possibly due to the signals transduced by the a3b1
integrin. The relatively low binding affinity of laminin-8 to-
ward a3b1/a6b1 integrins, as revealed by the relatively weak
cell adhesive activity of laminin-8, may also contribute to the
facilitation of rear cell detachment, even at high coating con-
centrations. Further studies are needed, however, to better
understand the molecular mechanisms of signaling pathways
through a3b1 and a6b1 integrins on laminin-8 and other lami-
nin isoforms.
Laminin isoforms containing the a4 chain have been shown
to be expressed strongly in embryonic and regenerating tissues,
where cells are actively migrating. For example, in developing
kidney, invading vessels that are destined to generate the
capillary loops of the glomeruli are surrounded by a basement
membrane rich in a4- but not a5-containing laminin isoforms
(23). During the late stages of kidney development, arteriolar
basement membranes lose a4 and acquire the a5 chain (23). In
the adult, expression of a4 chain-containing laminins is re-
stricted to the capillary basement membrane (22, 23, 26). Given
the remarkable potency of laminin-8 to promote cell migration,
selective expression of a4 chain-containing laminins in invad-
ing blood vessels during organogenesis and in capillary base-
ment membranes in the adult suggests that laminin-8 is in-
volved in endothelial cell migration during these processes. The
role of laminin-8 as a potent stimulator of cell migration is
consistent with the expression pattern of the a4 chain in mus-
cle, where it is expressed exclusively during development and
in the neuromuscular junctions of adults (26, 27). In addition,
the expression of the a4 chain is up-regulated in regenerating
muscle following a traumatic crushing injury (63). Further-
more, laminin-8 is one of the major components of neural crest
cell migration pathways. These pathways have been shown to
be blocked by an antibody against a laminin-8-agrin complex
(45, 64), indicating that laminin-8 is also involved in migration
of neural crest cells. Since these cells do not express a6 subunit-
containing integrins, the primary candidate for an integrin
operating during neural crest cell migration may be a3b1 (50),
the laminin-8 receptor most prominent in promoting cell mi-
gration. Further studies on the tissue distribution of laminin-8
under both normal and pathological conditions, as well as the
effects of laminin-8 on many other biological processes involv-
ing vast cell migration, should shed light on the roles of lami-
nin-8 in cell migration during development and tissue
regeneration.
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